ThinkSabio

$ATNM

$1.48▲ -0.7% YTD

11 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History
News
ATNM ▼ -0.7% - Actinium Pharmaceuticals, Inc.
CP $1.48▲ -0.7%Nov 2, 2026 · ThinkSabio Blog

$ATNM - Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resista…

News
ATNM ▼ -3.3% - Actinium Pharmaceuticals, Inc.
CP $1.48▲ -3.3%Oct 30, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces Inducement Grant to New Employee…

News
ATNM ▲ +0.6% - Actinium Pharmaceuticals, Inc.
CP $1.59▲ +0.6%Oct 23, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Can…

News
ATNM ▲ +3.0% - Actinium Pharmaceuticals, Inc.
CP $1.36▲ +3.0%Oct 20, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals Unveils ATNM?400 Data at EANM 2026 with a First?In?Human HER3?Targeted Radiotherapy Approach Beyond PSMA in…

News
ATNM ▲ +0.9% - Actinium Pharmaceuticals, Inc.
CP $1.13▲ +0.9%Oct 19, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals to Showcase ATNM-400's First-in-Human Clinical Data in Prostate Cancer and Preclinical Results in Lung Canc…

News
ATNM ▲ +4.8% - Actinium Pharmaceuticals, Inc.
CP $1.10▲ +4.8%Oct 16, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces Inducement Grants to New Employees…

News
ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.
CP $1.06▲ +1.0%Oct 16, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces Oral and Poster Presentations at EANM 2026 Highlighting Broad Antitumor Activity of ATNM-400 Acro…

News
ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.
CP $1.06▲ +1.0%Oct 16, 2026 · ThinkSabio Blog

$ATNM - Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development…

News
ATNM ▲ +4.2% - Actinium Pharmaceuticals, Inc.
CP $0.99▲ +4.2%Oct 15, 2026 · ThinkSabio Blog

$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces Oral Presentation at EANM 2026 Highlighting First-in-Human Phase 1 Study of ATNM-400, a Non-PSMA…

News
ATNM ▲ +2.1% - Actinium Pharmaceuticals, Inc.
CP $0.97▲ +2.1%Oct 15, 2026 · ThinkSabio Blog

$ATNM CRMD OVID - Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer…

News
ATNM ▼ -1.9% - Actinium Pharmaceuticals, Inc.
CP $1.03▲ -1.9%Sep 4, 2026 · ThinkSabio Blog

$ATNM - Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference…